Oncologic imaging: interactions of nuclear medicine with CT and MRI using the bone scan as a model.

[1]  F. W. Smith,et al.  CLINICAL APPLICATION OF NUCLEAR MAGNETIC RESONANCE , 1981, The Lancet.

[2]  M. Blau,et al.  Fluorine-18: a new isotope for bone scanning. , 1962, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[3]  N. Kennedy,et al.  Cost efficiency of bone scans in breast cancer. , 1991, Clinical oncology (Royal College of Radiologists (Great Britain)).

[4]  J. Muscat,et al.  Serum prostate-specific antigen as a predictor of radiographic staging studies in newly diagnosed prostate cancer. , 1995, Cancer Investigation.

[5]  L. White,et al.  Scintigraphic flare in skeletal lymphoma. , 1994, Clinical nuclear medicine.

[6]  K. Herrlin,et al.  Flare phenomenon in osteosarcoma after complete remission. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[7]  M. Gleave,et al.  Ability of serum prostate-specific antigen levels to predict normal bone scans in patients with newly diagnosed prostate cancer. , 1996, Urology.

[8]  D. Magid.  Two-dimensional and three-dimensional computed tomographic imaging in musculoskeletal tumors. , 1993, Radiologic clinics of North America.

[9]  M. Rossleigh,et al.  Serial Bone Scans in the Assessment of Response to Therapy in Advanced Breast Carcinoma , 1982, Clinical nuclear medicine.

[10]  A. Perruchoud,et al.  Initial staging of non-small cell lung cancer: value of routine radioisotope bone scanning. , 1991, Thorax.

[11]  E Kanal,et al.  MR procedures and biomedical implants, materials, and devices: 1993 update. , 1993, Radiology.

[12]  R. M. Peters,et al.  Multiorgan scans for staging lung cancer. Correlation with clinical evaluation. , 1977, The Journal of thoracic and cardiovascular surgery.

[13]  N. D. Charkes,et al.  EARLY DIAGNOSIS OF METASTATIC BONE CANCER BY PHOTOSCANNING WITH STRONTIUM-85. , 1964, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[14]  J. Fruhwirth,et al.  [A solitary metastasis in the trapezium bone]. , 1990, Der Radiologe.

[15]  M. Rossleigh,et al.  The assessment of response to therapy of bone metastases in breast cancer. , 1984, Australian and New Zealand journal of medicine.

[16]  D. Paushter,et al.  Clinical applications of nuclear magnetic resonance , 1984 .

[17]  W L Ashburn,et al.  The flare phenomenon on radionuclide bone scan in metastatic prostate cancer. , 1984, AJR. American journal of roentgenology.

[18]  J. McAfee,et al.  A new complex of 99mTc for skeletal imaging. , 1971, Radiology.

[19]  G. Hounsfield.  Computerized transverse axial scanning (tomography): Part I. Description of system. 1973. , 1973, The British journal of radiology.

[20]  V. Ratanatharathorn,et al.  Epidural spinal cord compression from metastatic tumor: diagnosis and guidelines for management. , 1991, Cancer treatment reviews.

[21]  B. Bagni,et al.  [Bone marrow scintigraphy in multiple myeloma. A comparison with bone scintigraphy and skeletal radiology]. , 1988, La Radiologia medica.

[22]  Historical vignette: introduction of computed tomography in North America. , 1993, AJNR. American journal of neuroradiology.

[23]  M. Garnick,et al.  Leuprolide Therapy for Prostate Cancer An Association with Scintigraphic “Flare” on Bone Scan , 1990, Clinical nuclear medicine.

[24]  D. Richel,et al.  Tumor and Therapy Associated Abnormal Changes on Bone Scintigraphy Old and New Phenomena , 1993, Clinical nuclear medicine.

[25]  S. Hashimoto,et al.  Radionuclide imaging of two patients with metastasis to a distal phalanx of the hand. , 1986, Clinical nuclear medicine.

[26]  M. Terris,et al.  Utilization of bone scans in conjunction with prostate-specific antigen levels in the surveillance for recurrence of adenocarcinoma after radical prostatectomy. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[27]  G. T. Krishnamurthy,et al.  Distribution pattern of metastatic bone disease. A need for total body skeletal image. , 1977, JAMA.

[28]  J. Oesterling,et al.  Prostate specific antigen in hormonally treated stage D2 prostate cancer: is it always an accurate indicator of disease status? , 1991, The Journal of urology.

[29]  B. McNeil.  Value of bone scanning in neoplastic disease. , 1984, Seminars in nuclear medicine.

[30]  P. Wingo,et al.  Cancer statistics, 1996 , 1996, CA: a cancer journal for clinicians.

[31]  J. Oesterling,et al.  The use of prostate-specific antigen in staging patients with newly diagnosed prostate cancer. , 1993, JAMA.

[32]  D. Ihde,et al.  Comparative value of bone scintigraphy and radiography in monitoring tumor response in systemically treated prostatic carcinoma. , 1983, Radiology.

[33]  H. Pretorius,et al.  Bone scintigraphy and multimodality imaging in bone neoplasia: strategies for imaging in the new health care climate. , 1994, Seminars in nuclear medicine.